Managers / Q4 2025 · view latest →
Birnam Oak Advisors, LP
CIK 0001997245 · 520 MADISON AVENUE, SUITE 2104, NEW YORK, NY, 10022 · 212-970-5800
Summary
Birnam Oak Advisors, LP reported $447M in U.S.-listed holdings across 51 positions for Q4 2025.
Its largest position, ACWI, represents 8.8% of the portfolio.
Compared with Q3 2025, the fund opened 11 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 68.1% · $304M
- ETP · 17.1% · $76M
- Other · 12.6% · $56M
- US DOMESTIC · 2.3% · $10M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| EAELECTRONIC ARTS INC | NEW | +151.0K | 151.0K | +$31M | $31M |
| CMACOMERICA INC | NEW | +333.6K | 333.6K | +$29M | $29M |
| DAYDAYFORCE INC | NEW | +359.9K | 359.9K | +$25M | $25M |
| AESAES CORP | NEW | +1.28M | 1.28M | +$18M | $18M |
| EXKEXACT SCIENCES CORP | NEW | +177.4K | 177.4K | +$18M | $18M |
| CDTXCIDARA THERAPEUTICS INC | NEW | +41.4K | 41.4K | +$9M | $9M |
| CATBUSDASTRIA THERAPEUTICS INC | NEW | +689.7K | 689.7K | +$9M | $9M |
| CADECADENCE BANK | NEW | +210.3K | 210.3K | +$9M | $9M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $441M | 51 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $447M | 51 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $435M | 49 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $338M | 36 | Aug 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $552M | 41 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $206M | 37 | Feb 10, 2025 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.